We are live on ! Find out more
AXDX

Accelerate Diagnostics
AXDX

Delisted

AXDX was delisted on the 14th of May, 2025.

Back to rankings

97 hedge funds and large institutions have $401M invested in Accelerate Diagnostics in 2015 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 39 increasing their positions, 15 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 15

100% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 11

59% more capital invested

Capital invested by funds: $252M → $401M (+$149M)

10% more funds holding

Funds holding: 88 → 97 (+9)

12% less call options, than puts

Call options by funds: $3.03M | Put options by funds: $3.46M

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
97
Holders Change
+9
Holders Change %
+10.23%
% of All Funds
2.55%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
22
Increased
39
Reduced
15
Closed
11
Calls
$3.03M
Puts
$3.46M
Net Calls
-$428K
Net Calls Change
+$1.56M

Top Buyers

1
MGM
Miura Global Management
New York
+$16.4M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$10.8M
3
N
Nuveen
North Carolina
+$5.32M
4
OIM
Oracle Investment Management
Connecticut
+$3.97M
5
DCM
Driehaus Capital Management
Illinois
+$2.9M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$2.16M
2
RCM
Raging Capital Management
New Jersey
-$1.41M
3
Group One Trading
Group One Trading
Illinois
-$1.13M
4
CS
Credit Suisse
Switzerland
-$606K
5
Stifel Financial
Stifel Financial
Missouri
-$518K
Name Holding Trade Value Shares
Change 		Change in
Stake
FBC
51
Fairfield, Bush & Co
Connecticut
$393K -$343K -1,880 -51%
UBS AM
52
UBS AM
Illinois
$367K – – –
MLICM
53
Metropolitan Life Insurance Company (MetLife)
New York
$362K – – –
Royal Bank of Canada
54
Royal Bank of Canada
Ontario, Canada
$335K +$236K +1,293 +481%
Tudor Investment Corp
55
Tudor Investment Corp
Connecticut
$329K +$280K +1,532 New
NFA
56
Nationwide Fund Advisors
Ohio
$310K +$7.3K +40 +3%
QSS
57
Quantitative Systematic Strategies
Florida
$302K +$255K +1,395 New
AQR Capital Management
58
AQR Capital Management
Connecticut
$286K -$131K -716 -35%
AIG
59
American International Group
New York
$271K -$365 -2 -0.2%
BF
60
BOK Financial
Oklahoma
$258K – – –
Bank of America
61
Bank of America
North Carolina
$251K +$101K +554 +90%
D.E. Shaw & Co
62
D.E. Shaw & Co
New York
$247K +$210K +1,148 New
MIM
63
Monashee Investment Management
Massachusetts
$246K +$209K +1,146 New
LCM
64
Laurion Capital Management
New York
$245K +$208K +1,140 New
Goldman Sachs
65
Goldman Sachs
New York
$242K +$205K +1,124 New
State Board of Administration of Florida Retirement System
66
State Board of Administration of Florida Retirement System
Florida
$225K +$191K +1,047 New
RG
67
Redmile Group
California
$215K +$183K +1,000 New
BA
68
BlackRock Advisors
Delaware
$213K -$82.7K -453 -31%
OAM
69
Oxford Asset Management
United Kingdom
$207K +$176K +964 New
GCP
70
GSA Capital Partners
United Kingdom
$206K +$175K +960 New
AL
71
Airain Ltd
Guernsey
$203K +$173K +946 New
Citigroup
72
Citigroup
New York
$186K +$112K +611 +242%
BG
73
BlackRock Group
United Kingdom
$149K -$3.29K -18 -3%
KP
74
Kiski Partners
New York
$121K +$103K +564 New
Deutsche Bank
75
Deutsche Bank
Germany
$115K -$27.2K -149 -22%
1 2
3
4 5

AXDX Hedge Fund Activity: Q4 2015 in Review

97 of the 3,811 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q4 2015, worth a combined $401M — up 59% from $252M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new AXDX positions and 11 closed out — a net gain of 11 holders — while 39 added to existing stakes and 15 trimmed.

The largest buyer was Miura Global Management, adding an estimated $16.4M. The largest seller was Millennium Management, cutting an estimated $2.16M.

  • 97 institutional investors held Accelerate Diagnostics (AXDX) as of Q4 2015, up from 88 in Q3 2015.
  • Funds reported $401M of Accelerate Diagnostics stock for Q4 2015, up 59% quarter-over-quarter.
  • 22 funds opened new Accelerate Diagnostics positions in Q4 2015 and 11 closed out, a net change of +11 holders.
  • The largest Accelerate Diagnostics buyer in Q4 2015 was Miura Global Management, an estimated $16.4M added.
  • The largest Accelerate Diagnostics seller in Q4 2015 was Millennium Management, an estimated $2.16M sold.

Based on aggregated 13F filings for Q4 2015.